✦ LIBER ✦

Impact of docetaxel-based chemotherapy on quality of life of patients with castration-resistant prostate cancer: results from a prospective phase II randomized trial

✍ Scribed by Orazio Caffo; Teodoro Sava; Evi Comploj; Annamaria Fariello; Fable Zustovich; Romana Segati; Cosimo Sacco; Antonello Veccia; Enzo Galligioni

Book ID: 110923754
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 415 KB
Volume: 108
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2011.10277.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccination of castration-resistant pros

Vaccination of castration-resistant prostate cancer patients with TroVax (MVA–5T4) in combination with docetaxel: a randomized phase II trial

✍ Richard Harrop, Franklin Chu, Nashat Gabrail… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 295 KB

IMPACT OF DOCETAXEL (D) – BASED CHEMOTHE

IMPACT OF DOCETAXEL (D) – BASED CHEMOTHERAPY ON QUALITY OF LIFE (QOL) OF PATIENTS (PTS) WITH HORMONE- REFRACTORY PROSTATE CANCER (HRPC): RESULTS FROM A RANDOMISED PHASE II TRIAL WITH D ± ESTRAMUSTINE (E)

✍ O. Caffo; T. Sava; E. Comploj; Z. Zustovich; R. Segati; A. Fariello; A. Perin; C 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

A randomized phase II study of cediranib

A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients

✍ Spreafico, Anna; Chi, Kim N.; Sridhar, Srikala S.; Smith, David C.; Carducci, Mi 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 518 KB

Patient-reported quality of life during

Patient-reported quality of life during radiation treatment for localized prostate cancer: results from a prospective phase II trial

✍ Ronald C. Chen; Yuanye Zhang; Ming-Hui Chen; Elizabeth McMahon; Marian Loffredo; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

P111 Final results of phase II study of

P111 Final results of phase II study of Gemcitabine-Oxalipaltin (GemOx) plus Prednisolone in patients with Castration-Resistant Prostate Cancer (CRPC) for whom Docetaxel-based chemotherapy failed

✍ Lee, J.-L.; Ahn, J.-H.; Choi, M.; Kim, Y.; Hong, S.-W.; Jeong, I.-G.; Song, C.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 66 KB

7004 Final results of a randomized phase

7004 Final results of a randomized phase II study of OGX-011 (OGX) in combination with docetaxel (DOC)/prednisone versus docetaxel/prednisone in patients with metastatic castration resistant prostate cancer (CRPC)

✍ Chi, K.N.; Hotte, S.J.; Yu, E.; Tu, D.; Eigl, B.; Tannock, I.; Saad, F.; North, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 53 KB